Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity

The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia. We reported comparative in vitro studies of combination effects of different cephalosporins (i.e., cefazolin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hung-Jen, Lai, Chih-Cheng, Chen, Chi-Chung, Zhang, Chun-Cheng, Weng, Tzu-Chieh, Yu, Wen-Liang, Chen, Hung-Jui, Chiu, Yu-Hsin, Ko, Wen-Chien, Chuang, Yin-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435797/
https://www.ncbi.nlm.nih.gov/pubmed/28572795
http://dx.doi.org/10.3389/fmicb.2017.00884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435797/
https://www.ncbi.nlm.nih.gov/pubmed/28572795
http://dx.doi.org/10.3389/fmicb.2017.00884

Ejemplares similares